Definitions

In addition to the definitions contained in T.C.A. § 63-10-601, the following definitions are applicable to this chapter: (1) “Board” means the Tennessee Board of Pharmacy; (2) “Central pharmacy” means the central pharmacy practice site licensed by the Tennessee Board of Pharmacy located within a federally qualified health center that is connected through computer link, videolink, and audiolink to one (1) or more satellite clinics; (3) “Dispense” shall have the same meaning as set forth in Tenn. Code Ann. § 63-10-204(12); (4) “Issue” means the delivery of drugs from the pharmacy technician employed by the federally qualified health center participating in this program to the patient or patient’s agent; (5) “Person” means any individual, partnership, association, corporation, or entity; (6) “Pharmacist” shall have the same meaning as set forth in Tenn. Code Ann. § 63-10-204(30) and who is an employee of a federally qualified health center participating in this program; (7) “Pharmacist-in-charge” shall have the same meaning as set forth in Tenn. Code Ann. § 63- 10-204(31) and who is an employee of a federally qualified health center participating in this program; (8) “Pharmacy practice site” shall have the same meaning as set forth in Tenn. Comp. R. & Regs. Rule 1140-01-.01(23); (9) “Pharmacy technician” means an individual registered by the Board as a pharmacy technician who is an employee of a federally qualified health center participating in this program and is being supervised by a pharmacist at the central pharmacy; PHARMACY PRACTICE IN FEDERALLY QUALIFIED HEALTH CENTERS CHAPTER 1140-13 (10) “Program” means the pilot program established in T.C.A. § 63-10-601 for the dispensing of medications (with the exception of controlled substances schedules I, II, III, and IV) from federally qualified health centers through the use of telepharmacy; (11) “Satellite clinic” means a clinic location located within federally qualified health center where any prescription dispensed at the central pharmacy shall be issued to the patient or patient’s agent through telepharmacy; (12) “Telepharmacy” means the method of providing pharmaceutical services through a remote site connection between a central pharmacy and a satellite clinic.